| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |